Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Amidation. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN119954669A details a mild solvent-free route for SNAC. This report analyzes cost reduction in pharmaceutical intermediates manufacturing and supply chain reliability.
Patent CN109111386A reveals a high-yield L-prolineamide synthesis. This report analyzes cost reduction and supply chain reliability for pharmaceutical manufacturers.
Patent CN113461648A discloses a streamlined 2-step synthesis for coumarin-based neuraminidase inhibitors, offering a cost-effective alternative to complex antiviral routes.
Patent CN106380441A reveals a cost-effective synthetic route for fexofenadine intermediates. Achieve high purity and scalable production for pharmaceutical supply chains.
Patent CN101817783B details a high-yield synthesis of Tolvaptan intermediates via optimized acid chloride activation, offering significant cost reduction in API manufacturing.
Novel Cu-catalyzed route for Flumatinib intermediate CN111763170A. Eliminates genotoxic impurities, reduces cost, ensures supply continuity for API manufacturing.
Novel process for VB0004 synthesis via Suzuki coupling. Offers high purity (>99%) and scalable route for API manufacturing cost reduction.
Patent CN111763209B details a novel Ruxolitinib synthesis avoiding expensive catalysts. Discover cost reduction in API manufacturing and high-purity pharmaceutical intermediates.
Patent CN101863954B details a high-yield route for Finasteride intermediates. Discover cost-effective manufacturing and scalable supply chain solutions for complex steroids.
Patent CN116178375B details a novel 5-step synthesis for anti-prostate cancer intermediates, offering cost reduction and supply chain reliability for pharmaceutical manufacturing.
Novel Idelalisib preparation method offers significant cost reduction and enhanced supply chain reliability for global pharmaceutical manufacturing partners seeking high-purity APIs.
Novel patent CN105315212A enables efficient Tolvaptan production. Reduces steps, avoids heavy metals. Reliable supply chain partner for pharma intermediates.
Patent CN102816083B reveals high-purity Lacosamide intermediate synthesis with strict temperature control and improved yield for reliable supply chain.
Patent CN114478439A details a novel post-treatment for Boc-piperazine, enabling high raw material recovery and cost reduction in pharmaceutical intermediates manufacturing.
Patent CN110283109B reveals a novel amidation-first route for Racecadotril, offering superior purity and scalable crystallization for reliable pharmaceutical intermediate supply.
Patent CN114315800B reveals a high-yield Topiroxostat synthesis route. Discover cost reduction in API manufacturing and supply chain advantages.
Advanced green synthesis of Prilocaine HCl via Patent CN102093248B. Eliminates toxic solvents, ensures high purity, and offers cost-effective scalable manufacturing for global API producers.
Novel Filgotinib synthetic method offers high yield and simplified operation. Reliable supplier for pharmaceutical intermediates with cost-effective scale-up solutions.
Patent CN103087046A reveals a cost-effective synthesis of dabigatran etexilate intermediates using thionyl chloride, offering significant yield improvements and supply chain stability.
Patent CN102617390A details a chelation-based route for high-purity epsilon-N-lauroyl lysine, offering superior regioselectivity and simplified purification for cosmetic manufacturers.